{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:39:10Z","timestamp":1769063950619,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25 CA094880"],"award-info":[{"award-number":["R25 CA094880"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA120562"],"award-info":[{"award-number":["R01 CA120562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","award":["N01-CN-67009"],"award-info":[{"award-number":["N01-CN-67009"]}],"id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","award":["N01-PC-35142"],"award-info":[{"award-number":["N01-PC-35142"]}],"id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10552-015-0599-z","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T04:38:26Z","timestamp":1431059906000},"page":"1065-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Associations between diabetes medication use and risk of second breast cancer events and mortality"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-3518","authenticated-orcid":false,"given":"Gregory S.","family":"Calip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onchee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent F.","family":"Hoskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"599_CR1","volume-title":"Breast cancer facts and figures\u00a02013\u20132014","author":"American Cancer Society","year":"2013","unstructured":"American Cancer Society (2013) Breast cancer facts and figures\u00a02013\u20132014. American Cancer Society Inc, Atlanta"},{"issue":"6","key":"599_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1200\/JOP.2011.000460","volume":"7","author":"CS Ritchie","year":"2011","unstructured":"Ritchie CS, Kvale E, Fisch MJ (2011) Multimorbidity: an issue of growing importance for oncologists. J Oncol Pract 7(6):371\u2013374. doi:\n                    10.1200\/JOP.2011.000460","journal-title":"J Oncol Pract"},{"issue":"7","key":"599_CR3","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. Diab Care 33(7):1674\u20131685. doi:\n                    10.2337\/dc10-0666","journal-title":"Diab Care"},{"issue":"2","key":"599_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","volume":"6","author":"I Wolf","year":"2005","unstructured":"Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103\u2013111. doi:\n                    10.1016\/S1470-2045(05)01736-5","journal-title":"Lancet Oncol"},{"issue":"1","key":"599_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2010.32.3022","volume":"29","author":"A DeCensi","year":"2011","unstructured":"DeCensi A, Gennari A (2011) Insulin breast cancer connection: confirmatory data set the stage for better care. J Clin Oncol 29(1):7\u201310. doi:\n                    10.1200\/JCO.2010.32.3022","journal-title":"J Clin Oncol"},{"issue":"10","key":"599_CR6","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/annonc\/mdt224","volume":"24","author":"S Jiralerspong","year":"2013","unstructured":"Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH (2013) Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol 24(10):2506\u20132514. doi:\n                    10.1093\/annonc\/mdt224","journal-title":"Ann Oncol"},{"issue":"2","key":"599_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-010-1035-4","volume":"125","author":"CI Li","year":"2011","unstructured":"Li CI, Daling JR, Tang MT, Malone KE (2011) Relationship between diabetes and risk of second primary contralateral breast cancer. Breast Cancer Res Treat 125(2):545\u2013551. doi:\n                    10.1007\/s10549-010-1035-4","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"599_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","volume":"29","author":"KS Peairs","year":"2011","unstructured":"Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Derr RL, Brancati FL, Wolff AC (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29(1):40\u201346. doi:\n                    10.1200\/JCO.2009.27.3011","journal-title":"J Clin Oncol"},{"issue":"23","key":"599_CR9","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1200\/JCO.2011.39.7505","volume":"30","author":"RT Chlebowski","year":"2012","unstructured":"Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, Kaklamani VG, Vitolins M, Wallace R, Gunter M, Phillips LS, Strickler H, Margolis K, Euhus DM (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 30(23):2844\u20132852. doi:\n                    10.1200\/JCO.2011.39.7505","journal-title":"J Clin Oncol"},{"issue":"1","key":"599_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00125-011-2312-4","volume":"55","author":"R Ruiter","year":"2012","unstructured":"Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, Straus SM, Herings RM, Stricker BH (2012) Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia 55(1):51\u201362. doi:\n                    10.1007\/s00125-011-2312-4","journal-title":"Diabetologia"},{"issue":"1","key":"599_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pcd.2011.10.004","volume":"6","author":"M Lind","year":"2012","unstructured":"Lind M, Fahlen M, Eliasson B, Oden A (2012) The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes. Prim Care Diab 6(1):53\u201359. doi:\n                    10.1016\/j.pcd.2011.10.004","journal-title":"Prim Care Diab"},{"issue":"9","key":"599_CR12","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00125-011-2190-9","volume":"54","author":"S Suissa","year":"2011","unstructured":"Suissa S, Azoulay L, Dell\u2019Aniello S, Evans M, Vora J, Pollak M (2011) Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia 54(9):2254\u20132262. doi:\n                    10.1007\/s00125-011-2190-9","journal-title":"Diabetologia"},{"issue":"6","key":"599_CR13","doi-asserted-by":"publisher","first-page":"e21368","DOI":"10.1371\/journal.pone.0021368","volume":"6","author":"CH Chang","year":"2011","unstructured":"Chang CH, Toh S, Lin JW, Chen ST, Kuo CW, Chuang LM, Lai MS (2011) Cancer risk associated with insulin glargine among adult type 2 diabetes patients\u2013a nationwide cohort study. PLoS ONE 6(6):e21368. doi:\n                    10.1371\/journal.pone.0021368","journal-title":"PLoS ONE"},{"issue":"9","key":"599_CR14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2337\/dc11-0699","volume":"34","author":"NE Morden","year":"2011","unstructured":"Morden NE, Liu SK, Smith J, Mackenzie TA, Skinner J, Korc M (2011) Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients. Diab Care 34(9):1965\u20131971. doi:\n                    10.2337\/dc11-0699","journal-title":"Diab Care"},{"issue":"9","key":"599_CR15","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","volume":"52","author":"CJ Currie","year":"2009","unstructured":"Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52(9):1766\u20131777. doi:\n                    10.1007\/s00125-009-1440-6","journal-title":"Diabetologia"},{"issue":"6","key":"599_CR16","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","volume":"16","author":"AM Gonzalez-Angulo","year":"2010","unstructured":"Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16(6):1695\u20131700. doi:\n                    10.1158\/1078-0432.CCR-09-1805","journal-title":"Clin Cancer Res"},{"issue":"20","key":"599_CR17","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","volume":"27","author":"S Jiralerspong","year":"2009","unstructured":"Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297\u20133302. doi:\n                    10.1200\/JCO.2009.19.6410","journal-title":"J Clin Oncol"},{"issue":"21","key":"599_CR18","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1200\/JCO.2011.39.3769","volume":"30","author":"B Bonanni","year":"2012","unstructured":"Bonanni B, Puntoni M, Cazzaniga M, Pruneri G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS, Galimberti V, Veronesi P, Johansson H, Aristarco V, Bassi F, Luini A, Lazzeroni M, Varricchio C, Viale G, Bruzzi P, Decensi A (2012) Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol 30(21):2593\u20132600. doi:\n                    10.1200\/JCO.2011.39.3769","journal-title":"J Clin Oncol"},{"issue":"3","key":"599_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00125-011-2429-5","volume":"55","author":"P Blin","year":"2012","unstructured":"Blin P, Lassalle R, Dureau-Pournin C, Ambrosino B, Bernard MA, Abouelfath A, Gin H, Le Jeunne C, Pariente A, Droz C, Moore N (2012) Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. Diabetologia 55(3):644\u2013653. doi:\n                    10.1007\/s00125-011-2429-5","journal-title":"Diabetologia"},{"issue":"6","key":"599_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","volume":"49","author":"P Kurtzhals","year":"2000","unstructured":"Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49(6):999\u20131005","journal-title":"Diabetes"},{"issue":"3","key":"599_CR21","doi-asserted-by":"publisher","first-page":"e9540","DOI":"10.1371\/journal.pone.0009540","volume":"5","author":"MR Sommerfeld","year":"2010","unstructured":"Sommerfeld MR, Muller G, Tschank G, Seipke G, Habermann P, Kurrle R, Tennagels N (2010) In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. PLoS ONE 5(3):e9540. doi:\n                    10.1371\/journal.pone.0009540","journal-title":"PLoS ONE"},{"issue":"2","key":"599_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/13813451003631439","volume":"116","author":"D Mayer","year":"2010","unstructured":"Mayer D, Chantelau E (2010) Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells. Arch Physiol Biochem 116(2):73\u201378. doi:\n                    10.3109\/13813451003631439","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"599_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-014-2870-5","volume":"144","author":"DM Boudreau","year":"2014","unstructured":"Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS (2014) Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat 144(2):405\u2013416. doi:\n                    10.1007\/s10549-014-2870-5","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"599_CR24","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-13-0454","volume":"22","author":"HS Wirtz","year":"2013","unstructured":"Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM (2013) Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev 22(9):1588\u20131599. doi:\n                    10.1158\/1055-9965.EPI-13-0454","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"599_CR25","unstructured":"Surveillance Epidemiology and End Results (SEER) Program Overview of the SEER Program \n                    http:\/\/seer.cancer.gov\/about\/overview.html"},{"key":"599_CR26","first-page":"223","volume-title":"Pharmacoepidemiology","author":"KW Saunders","year":"2005","unstructured":"Saunders KW, Davis RL, Stergachis A (2005) Group health cooperative. In: Strom BL (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester, pp 223\u2013239","edition":"4"},{"issue":"7\u20138","key":"599_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1345\/aph.1D569","volume":"38","author":"DM Boudreau","year":"2004","unstructured":"Boudreau DM, Doescher MP, Jackson JE, Fishman PA, Saver BG (2004) Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications. Ann Pharmacother 38(7\u20138):1317\u20131318. doi:\n                    10.1345\/aph.1D569","journal-title":"Ann Pharmacother"},{"issue":"7","key":"599_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1532-5415.2004.52311.x","volume":"52","author":"DS Buist","year":"2004","unstructured":"Buist DS, LaCroix AZ, Brenneman SK, Abbott T 3rd (2004) A population-based osteoporosis screening program: who does not participate, and what are the consequences? J Am Geriatr Soc 52(7):1130\u20131137. doi:\n                    10.1111\/j.1532-5415.2004.52311.x","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"599_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0039-6109(03)00034-3","volume":"83","author":"SE Singletary","year":"2003","unstructured":"Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2003) Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 83(4):803\u2013819. doi:\n                    10.1016\/S0039-6109(03)00034-3","journal-title":"Surg Clin North Am"},{"key":"599_CR30","unstructured":"Group Health Breast Cancer Surveillance Registry \n                    http:\/\/www.grouphealthresearch.org\/surveillanceproject\n                    \n                  . Accessed 15 June 2011"},{"key":"599_CR31","unstructured":"Washington State Department of Health, Center for Health Statistics. Death Data. \n                    http:\/\/www.doh.wa.gov\/DataandStatisticalReports\/VitalStatisticsData\/DeathData\n                    \n                  . Accessed 15 June 2011"},{"issue":"6","key":"599_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/106286069901400607","volume":"14","author":"PL Hebert","year":"1999","unstructured":"Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM (1999) Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14(6):270\u2013277","journal-title":"Am J Med Qual"},{"issue":"10","key":"599_CR33","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.2337\/diacare.26.10.2810","volume":"26","author":"KM Newton","year":"2003","unstructured":"Newton KM, LaCroix AZ, Heckbert SR, Abraham L, McCulloch D, Barlow W (2003) Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes. Diab Care 26(10):2810\u20132816","journal-title":"Diab Care"},{"issue":"3","key":"599_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0895-4356(98)00161-9","volume":"52","author":"KM Newton","year":"1999","unstructured":"Newton KM, Wagner EH, Ramsey SD, McCulloch D, Evans R, Sandhu N, Davis C (1999) The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol 52(3):199\u2013207","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"599_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diab Care 32(1):193\u2013203. doi:\n                    10.2337\/dc08-9025","journal-title":"Diab Care"},{"issue":"15","key":"599_CR36","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","volume":"25","author":"CA Hudis","year":"2007","unstructured":"Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA (2007) Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 25(15):2127\u20132132. doi:\n                    10.1200\/JCO.2006.10.3523","journal-title":"J Clin Oncol"},{"issue":"6 Suppl","key":"599_CR37","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1097\/MLR.0b013e3181d99107","volume":"48","author":"R Varadhan","year":"2010","unstructured":"Varadhan R, Weiss CO, Segal JB, Wu AW, Scharfstein D, Boyd C (2010) Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care 48(6 Suppl):S96\u2013105. doi:\n                    10.1097\/MLR.0b013e3181d99107","journal-title":"Med Care"},{"issue":"5","key":"599_CR38","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/cncr.26439","volume":"118","author":"S Bayraktar","year":"2012","unstructured":"Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM (2012) Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer 118(5):1202\u20131211. doi:\n                    10.1002\/cncr.26439","journal-title":"Cancer"},{"issue":"10","key":"599_CR39","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.2337\/dc12-2535","volume":"36","author":"IC Lega","year":"2013","unstructured":"Lega IC, Austin PC, Gruneir A, Goodwin PJ, Rochon PA, Lipscombe LL (2013) Association between metformin therapy and mortality after breast cancer: a population-based study. Diab Care 36(10):3018\u20133026. doi:\n                    10.2337\/dc12-2535","journal-title":"Diab Care"},{"issue":"5","key":"599_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2174\/15680266113136660069","volume":"8","author":"PJ Peeters","year":"2013","unstructured":"Peeters PJ, Bazelier MT, Vestergaard P, Leufkens HG, Schmidt MK, de Vries F, De Bruin ML (2013) Use of metformin and survival of diabetic women with breast cancer. Curr Drug Saf 8(5):357\u2013363","journal-title":"Curr Drug Saf"},{"issue":"7","key":"599_CR41","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/annonc\/mdr534","volume":"23","author":"X He","year":"2012","unstructured":"He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC (2012) Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+\u00a0breast cancer. Ann Oncol 23(7):1771\u20131780. doi:\n                    10.1093\/annonc\/mdr534","journal-title":"Ann Oncol"},{"issue":"6","key":"599_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613\u2013619","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"599_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/pds.3660","volume":"24","author":"GS Calip","year":"2015","unstructured":"Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM (2015) Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiol Drug Saf 24(1):75\u201385. doi:\n                    10.1002\/pds.3660","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"19","key":"599_CR44","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/jnci\/djt211","volume":"105","author":"J Chubak","year":"2013","unstructured":"Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS (2013) Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst 105(19):1456\u20131462. doi:\n                    10.1093\/jnci\/djt211","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"599_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10549-014-2998-3","volume":"146","author":"SA Sabatino","year":"2014","unstructured":"Sabatino SA, Thompson TD, Wu XC, Fleming ST, Kimmick GG, Trentham-Dietz A, Cress R, Anderson RT (2014) The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer. Breast Cancer Res Treat 146(1):199\u2013209. doi:\n                    10.1007\/s10549-014-2998-3","journal-title":"Breast Cancer Res Treat"},{"issue":"9113","key":"599_CR46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351(9113):1393\u20131396. doi:\n                    10.1016\/S0140-6736(97)10384-1","journal-title":"Lancet"},{"key":"599_CR47","unstructured":"Goodwin PJ ClinicalTrials.gov\u2014A phase III randomized trial of metformin versus placebo on recurrence and survival in early stage breast cancer NCT01101438, Accessed 18 Feb 2014"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-015-0599-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0599-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:58:37Z","timestamp":1589659117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-015-0599-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s10552-015-0599-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]},"assertion":[{"value":"5 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}